Nestlé proposes P&G’s Fama Francisco, ex-SNB chief Thomas Jordan to board
Nestlé proposes Ma. Fatima D. Francisco and Thomas Jordan for its Board at the April 16, 2026 AGM, aiming to boost governance and expertise with…
Latest News
Alembic Pharma completes USFDA inspection at Karakhadi, Gujarat facility with two observations
Shares of Alembic Pharmaceuticals Ltd ended at ₹773.70, down by ₹2.70, or 0.35%, on the BSE.
BGR Energy Systems closes ₹634 crore Rajasthan VAT case; pays ₹29 crore under amnesty
Shares of BGR Energy Systems Ltd ended at ₹346.65, up by ₹16.25, or 4.92%, on the BSE.
Cochin Shipyard signs $360 million mega deal with French firm CMA CGM for six LNG vessels
Shares of Cochin Shipyard Ltd ended at ₹1,529.60, up by ₹3.35, or 0.22%, on the BSE.
Wall Street rises as Nvidia gains on Meta AI data center deal
Nvidia gained 2.2% after Meta Platforms announced a long-term partnership to build data centers using millions of Nvidia chips and related equipment to support its…
Trade Setup for February 19: Nifty holds above 25,800; Street sees move towards 26,000 and beyond
The technical setup favours Nifty bulls, with the index holding above key moving averages.
SEBI sets up working group to review ESG rating provider framework
SEBI has constituted a working group to review the regulatory framework for ESG Rating Providers, aiming to strengthen transparency, reliability and investor confidence amid evolving…
Dr Reddy’s boosts gynaecology portfolio, acquires HRT brands from Mercury Pharma for $32.2 mn
Dr Reddy’s announced the acquisition of the trademarks Progynova and CycloProgynova and related assets in India from Mercury Pharma Group Ltd. Shares of Dr Reddy’s…
HUL approves ₹2,000-cr investment to expand premium beauty & well-being, home care biz
The investment aligns with HUL’s strategy of focusing on fewer, bigger bets and strengthening its presence in high-growth demand areas, including premium skin care, hair…
Stocks to Watch for Feb 19: Zydus Life, TVS Motor, NCC, Jindal Saw and more
From NCC and its step-down subsidiary OB Infrastructure receiving an order of debarment from the NHAI to Zydus Lifesciences getting final approval from the USFDA…